In this blog for people with severe arthritis Robert Walton, Senior Fellow in General Practice at Cochrane UK and a very general practitioner, examines Cochrane evidence about biologics, a new generation of drugs to help people with this disabling long term condition.
Tag: rheumatoid arthritis
TNF inhibitors in Rheumatoid Arthritis: is dose reduction safe and effective for all?
Professor Paul Bowness, Consultant Rheumatologist in Oxford UK, discusses the implications of Cochrane evidence on down-titration and discontinuation of TNFi therapies in Rheumatoid Arthritis.